scholarly journals Blood Parameters and Feline Tooth Resorption: A Retrospective Case Control Study from a Spanish University Hospital

Animals ◽  
2021 ◽  
Vol 11 (7) ◽  
pp. 2125
Author(s):  
Ana Whyte ◽  
María Teresa Tejedor ◽  
Jaime Whyte ◽  
Luis Vicente Monteagudo ◽  
Cristina Bonastre

Tooth resorption (TR; progressive destruction of hard dental tissues) varies in prevalence according to population, age, and country (29–66.1%). Our objective was twofold: describing the TR clinical presentation in Northeastern Spain, and studying 34 blood parameters to ascertain potential systemic effects associated with TR. Cases (29; presented from September 2018 to May 2019) and controls (58) were considered. Non-parametric tests were carried out to compare cases and controls for each blood parameter; those showing significant differences were chosen for multiple regression analysis (binomial logistic and hierarchical multiple regressions). In case TR was detected in 130/870 teeth (14.9%), TR stage and type were correlated (p < 0.001). Increasing CREA values (p = 0.034) and decreasing BUN/CREA and ALB/GLOB values were associated with TR presence (p = 0.029 and p = 0.03, respectively). Increasing GLOB was associated with increasing severity of TR (p < 0.01). Type 1 TR (highly related to inflammation and periodontal disease PD) was the most frequently observed type; the association of TR and inflammation biomarkers (ALB/GLOB, GLOB) are explained by this fact. The concomitant presence of PD and TR in old cats would cause TR association with kidney damage biomarkers (CREA, BUN/CREA). When affected by TR, special care in these aspects must be provided to cats.

2021 ◽  
Author(s):  
Zuzana Kremenova ◽  
Jan Svancara ◽  
Petra Kralova ◽  
Martin Moravec ◽  
Katerina Hanouskova ◽  
...  

Abstract Background: More than 50% of patients worldwide die in hospitals. It is well known that end-of-life hospital care is costly.Our aims were to test whether the support of the palliative team can reduce end-of-life costs and to study the mechanisms of cost reduction.Methods: This was a one-centre descriptive retrospective case-control study. Big data from registries of routine visits were used for case-control matching. We included the expenses billed to the insurance company and added separately charged drugs and materials. We compared the groups over the duration of the terminal hospitalization, ICU days (ICU=intensive care unit), IV antibiotic use (IV=intravenous), MRI/CT scans (MRI/CR=magnetic resonance imaging/computed tomography), oncologic treatment in the last month of life, and documentation of the dying phase.We searched for all in-hospital cases who died in the university hospital in Prague with the support of the hospital palliative team from January 2019 to April 2020 and matched them with similar controls. The controls were matched according to age, sex, Charlson comorbidity index and diagnosis recorded on the death certificate.Results: We identified 213 dyads. The average daily costs were three times lower in the palliative group (4,392.4 CZK per day=171.3 EUR) than in the non-palliative group (13,992.8 CZK per day=545.8 EUR), and the difference was caused by the shorter time spent in the ICU (16% vs 33% of hospital days). This was probably due to better documentation of the dying phase in the medical records.Conclusions: To date, there are sparse hospital data available on the economic aspects of end-of-life care. We showed that the integration of the palliative care team in the dying phase can be cost saving. The evidence that hospital palliative care can save a substantial amount of money can be used to support the integration of palliative care in hospitals in middle- and low-income countries. A multicentre study with the same design is planned in the future to increase the strength of the results.


2017 ◽  
Vol 24 (2) ◽  
pp. 229-239
Author(s):  
Alda Troncone ◽  
Antonietta Chianese ◽  
Angela Zanfardino ◽  
Crescenzo Cascella ◽  
Santino Confetto ◽  
...  

This study examined nonverbal intelligence and scholastic achievement in children with type 1 diabetes. In a retrospective case–control study, 69 children (35 males) ages 5–10 years with type 1 diabetes and 69 healthy controls matched to patients by age, gender and socioeconomic status were compared according to their performance on Raven’s Coloured Progressive Matrices and their scholastic grades. No differences in nonverbal intelligence and grades were observed between children with type 1 diabetes and healthy control subjects. Raven’s Coloured Progressive Matrices scores inversely correlated with duration of illness both in children with early onset of type 1 diabetes and poor metabolic control. Possible explanations of the results and implications are discussed.


2021 ◽  
Vol 10 (6) ◽  
pp. 1153
Author(s):  
Enrique S. Meseguer ◽  
Mikel U. Elizalde ◽  
Alberto M. Borobia ◽  
Elena Ramírez

Introduction: Valproic acid (VPA) is an antiepileptic drug extensively used for treating partial and generalised seizures, acute mania and as prophylaxis for bipolar disorder. Drug-induced liver injury (DILI) persists as a significant issue related to fatal outcomes by VPA. The aim of this study was to increase our knowledge about this condition and to better identify patients affected. Methods: We conducted an observational retrospective case-control study that identified cases of DILI by VPA from the Pharmacovigilance Programme from our Laboratory Signals at La Paz University Hospital from January 2007 to December 2019. From the Therapeutic VPA Monitoring program, two control groups were assigned, VPA-tolerant patients and the other with patients who developed mild VPA-related liver injury but who did not meet the DILI criteria, matched for date, age and sex. Results: A total of 60 patients were included in the study: 15 cases of DILI, 30 VPA-tolerant controls and 15 controls with mild liver injury. Mean age for the cases was 45.7 years, 4 (26.7%) were women and 5 (33.34%) were children under 18 years, of them 3 (20%) were fatal. Polytherapy with other antiepileptic drugs (p = 0.047) and alcohol consumption (p < 0.001) were associated with a greater risk of developing DILI by VPA. A diagnosis of epileptic seizure was more frequently related to DILI when compared with the VPA-tolerant controls (p < 0.001). The cases developed hepatocellular liver injury (p < 0.001), while the mild hepatic damage controls had a higher rate of cholestatic liver injury (p < 0.001). The laboratory lactate dehydrogenase values were statistically higher (even at baseline) in patients with DILI than in both control groups (p = 0.033 and p = 0.039). Conclusions: VPA hepatotoxicity remains a considerable problem. This study offers interesting findings for characterising VPA-induced liver injury and at-risk patients.


2020 ◽  
Author(s):  
Peter Thingholm ◽  
Amanda Gaulke ◽  
Tine M. Eriksen ◽  
Jannet Svensson ◽  
Niels Skipper

<b>Objectives </b>To investigate school absenteeism before the clinical diagnosis in children who developed type 1 diabetes. <p> </p> <p><b>Research Design and Methods </b>Population based retrospective case control study involving all Danish public-school children that developed type 1 diabetes (n= 1 338) from 2010-2017 matched 1:5 on sex and date of birth to children without diabetes (n= 6 690). Monthly absenteeism was compared 12 months before to 12 months after the diagnosis of type 1 diabetes. </p> <p><b> </b></p> <p><b>Results</b> Seven to 12 months before the diabetes diagnosis the mean (SD) number of days absent from school per month was 0.93 (1.78) among children with diabetes and 0.93 (1.82) among controls (difference: -0.004 days, <i>p=</i>0.94). From 4 months before diagnosis, children who developed diabetes had a statistically significant increase in absenteeism compared with controls (difference: 0.24 days, <i>p</i><0.05). </p> <p> </p> <p><b>CONCLUSION </b>Children who were diagnosed with type 1 diabetes had increased school absenteeism 4 months prior to diagnosis. </p>


Author(s):  
Enrique Seco Meseguer ◽  
Mikel Urroz Elizalde ◽  
Alberto M. Borobia ◽  
Elena Ramírez

Introduction: Valproic acid (VPA) is an antiepileptic drug extensively used for treating partial and generalised seizures, acute mania and as prophylaxis for bipolar disorder. Drug-induced liver injury (DILI) persists as a significant issue related to fatal outcomes by VPA. The aim of this study was to increase our knowledge about this condition and to better identify patients affected. Methods: We conducted an observational retrospective case-control study that identified cases of DILI by VPA from the Pharmacovigilance Programme from our Laboratory Signals at La Paz University Hospital from January 2007 to December 2019. From the Therapeutic VPA Monitoring Programme, two control groups were assigned, VPA-tolerant patients and the other with patients who developed mild VPA-related hepatitis but who did not meet the DILI criteria, matched for date, age and sex. Results: A total of 60 patients were included in the study: 15 cases of DILI, 30 VPA-tolerant controls and 15 controls with mild hepatitis. Mean age for the cases was 45.7 years, 4(26.7%) were women and 5(33.34%) were children under 18 years, of them 3(20%) were fatal. Polytherapy with other antiepileptic drugs (p=0.047) and alcohol consumption (p&lt;0.001) were associated with a greater risk of developing DILI by VPA. A diagnosis of epileptic seizure was more frequently related to DILI when compared with the VPA-tolerant controls (p&lt;0.001). The cases developed hepatocellular hepatitis (p&lt;0.001), while the mild hepatitis controls had a higher rate of cholestatic hepatitis (p&lt;0.001). The laboratory lactate dehydrogenase values were statistically higher (even at baseline) in patients with DILI than in both control groups (p= 0.033 and p=0.039). Conclusions: VPA hepatotoxicity remains a considerable problem. This study offers interesting findings for characterising VPA-induced liver injury and at-risk patients.


BMJ Open ◽  
2019 ◽  
Vol 9 (5) ◽  
pp. e026375 ◽  
Author(s):  
Marie-Pierre Tavolacci ◽  
Quentin Berthon ◽  
Damiano Cerasuolo ◽  
Pierre Dechelotte ◽  
Joel Ladner ◽  
...  

ObjectiveA retrospective case–control study was conducted to evaluate whether frequent binge drinking between the age of 18 and 25 years was a risk factor for alcohol dependence in adulthood.SettingThe Department of Addictive Medicine and the Clinical Investigation Center of a university hospital in France.ParticipantsCases were alcohol-dependent patients between 25 and 45 years and diagnosed by a psychiatrist. Consecutive patients referred to the Department of Addictive Medicine of a university hospital between 1 January 2017 and 31 December 2017 for alcohol dependence were included in the study. Controls were non-alcohol-dependent adults, defined according to an Alcohol Use Disorders Identification Test score of less than 8, and were matched on age and sex with cases. Data on sociodemographics, behaviour and alcohol consumption were retrospectively collected for three life periods: before the age of 18 years; between the age of 18 and 25 years; and between the age of 25 and 45 years. Frequency of binge drinking between 18 and 25 years was categorised as frequent if more than twice a month, occasional if once a month and never if no binge drinking.Results166 adults between 25 and 45 years were included: 83 were alcohol-dependent and 83 were non-alcohol-dependent. The mean age was 34.6 years (SD: 5.1). Frequent binge drinking between 18 and 25 years occurred in 75.9% of cases and 41.0% of controls (p<0.0001). After multivariate analysis, frequent binge drinking between 18 and 25 years was a risk factor for alcohol dependence between 25 and 45 years: adjusted OR=2.83, 95% CI 1.10 to 7.25.ConclusionsFrequent binge drinking between 18 and 25 years appears to be a risk factor for alcohol dependence in adulthood. Prevention measures for binge drinking during preadulthood, especially frequent binge drinking, should be implemented to prevent acute consequences as injury and death and long-term consequences as alcohol dependence.Trial registration numberNCT03204214; Results.


2020 ◽  
Author(s):  
Peter Thingholm ◽  
Amanda Gaulke ◽  
Tine M. Eriksen ◽  
Jannet Svensson ◽  
Niels Skipper

<b>Objectives </b>To investigate school absenteeism before the clinical diagnosis in children who developed type 1 diabetes. <p> </p> <p><b>Research Design and Methods </b>Population based retrospective case control study involving all Danish public-school children that developed type 1 diabetes (n= 1 338) from 2010-2017 matched 1:5 on sex and date of birth to children without diabetes (n= 6 690). Monthly absenteeism was compared 12 months before to 12 months after the diagnosis of type 1 diabetes. </p> <p><b> </b></p> <p><b>Results</b> Seven to 12 months before the diabetes diagnosis the mean (SD) number of days absent from school per month was 0.93 (1.78) among children with diabetes and 0.93 (1.82) among controls (difference: -0.004 days, <i>p=</i>0.94). From 4 months before diagnosis, children who developed diabetes had a statistically significant increase in absenteeism compared with controls (difference: 0.24 days, <i>p</i><0.05). </p> <p> </p> <p><b>CONCLUSION </b>Children who were diagnosed with type 1 diabetes had increased school absenteeism 4 months prior to diagnosis. </p>


Sign in / Sign up

Export Citation Format

Share Document